Health TrialsbyHealthPanel

The Effects of Time Points to Cease Parenteral Nutrition and IGF-1 on Very Low Birth Weight Infants

ConditionGrowth Retardation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorPeking University

About this trial

This study aims to estimate short-term and long-term effects of time points to cease parenteral nutrition on very preterm infants, such as growth; to estimate the role of insulin-like growth factor 1 in the growth.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Infants with a birth weight less than 1500 grams

Infants admitted within 72 hours after birth

Infants born from July 1, 2023, to June 30, 2024

Written informed consent from parents or guardians

Disqualifiers

Infants with congenital abnormality

Infants surviving <7 days after birth

Trial population

Very low birth weight infants(birth weight less than 1500 grams)

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • (enteral feeding volume/ total fluid volume)*100%

    Other intervention

    (enteral feeding volume/ total fluid volume)\*100%. Total fluid volume is defined as enteral feeding volume + parenteral fluid volume + other fluid volume

Treatment groups

416 Participants
are divided into 3 treatment groups
Group A: 60-70% group1 intervention
Group B: 71-80% group1 intervention
Group C: 81-90% group1 intervention

Trial outcomes

Primary outcomes

1

short-term weight and long-term weight

weight

Time frame
at 36 weeks' corrected age (CA), CA 3 months, CA 6 months, CA 12 months, CA 18 months, CA 24 months, 36 months' age, 48 months' age and 60 months' age
2

short-term head circumference and long-term head circumference

head circumference

Time frame
at 36 weeks' corrected age (CA), CA 3 months, CA 6 months, CA 12 months, CA 18 months, CA 24 months, 36 months' age, 48 months' age and 60 months' age
3

short-term length and long-term length

length

Time frame
at 36 weeks' corrected age (CA), CA 3 months, CA 6 months, CA 12 months, CA 18 months, CA 24 months, 36 months' age, 48 months' age and 60 months' age

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Peking University

Lead sponsor

Source ClinicalTrials.gov
Apply now